Why Root Shares Are Trading Higher By 50%; Here Are 20 Stocks Moving Premarket
Gainers
ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 100.8% to $2.65 in pre-market trading after dropping 43% on Wednesday.
Why ToughBuilt Industries Shares Are Trading Lower By Over 46%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Advanced Health Intelligence Ltd. (NASDAQ: AHI) shares jumped 209.5% to $2.29 after the company signed a Letter of Intention with UAE-Based e-script medicine management company Pharmak Pharmacy.
Why Novavax Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Reata Pharmaceuticals Inc (NASDAQ: RETA) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia.
Why Titan International Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) shares jumped 153% to $3.24 after the company announced the launch of PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.
12 Health Care Stocks Moving In Tuesday’s Intraday Session
Gainers Cardio Diagnostics Hldgs (NASDAQ:CDIO) stock moved upwards by 137.1% to $3.17 during Tuesday’s regular session. Trading volume…
12 Health Care Stocks Moving In Monday’s Intraday Session
Gainers SmileDirectClub (NASDAQ:SDC) stock increased by 47.0% to $0.71 during Monday’s regular session. SmileDirectClub’s stock is trading at…
Catalyst Biosciences And GNI Group Sign Agreements Fro Sale And Purchase Of F351 Program; Announces $7.5M Special Divided And Contingent Value Right
Acquires F351, a Phase 3 Drug to Treat Fibrosis
Will Acquire Controlling Interest in Continent, a China-Based Commercial Pharma Company, from the GNI Group in Subsequent Transaction
Announces $7.5
How Is The Market Feeling About Catalyst Biosciences?
Catalyst Biosciences's (NASDAQ:CBIO) short percent of float has fallen 48.42% since its last report. The company recently reported that it has 918 thousand shares sold short, which is 2.94% of all regular shares that are available for trading.
Catalyst Biosciences Q2 EPS $1.64 Up From $(0.64) YoY
Catalyst Biosciences (NASDAQ:CBIO) reported quarterly earnings of $1.64 per share. This is a 356.25 percent increase over losses of $(0.64) per share from the same period last year.